Crossref
Payers endorse generics to enhance prescribing efficiency: impact and future implications, a case history approach
Generics and Biosimilars Initiative Journal · 2012
DOI: 10.5639/gabij.2012.0102.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Generics and Biosimilars Initiative Journal, 2012. Verfasst von Brian Godman. Die Arbeit wurde bisher 30-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Godman, B. (2012). Payers endorse generics to enhance prescribing efficiency: impact and future implications, a case history approach. Generics and Biosimilars Initiative Journal. https://doi.org/10.5639/gabij.2012.0102.017
Vancouver
Godman B. Payers endorse generics to enhance prescribing efficiency: impact and future implications, a case history approach. Generics and Biosimilars Initiative Journal. 2012. doi:10.5639/gabij.2012.0102.017
BibTeX
@article{Godman2012,
author = {Godman, Brian},
title = {Payers endorse generics to enhance prescribing efficiency: impact and future implications, a case history approach},
journal = {Generics and Biosimilars Initiative Journal},
year = {2012},
doi = {10.5639/gabij.2012.0102.017}
}
EUVIMED